Sugi Predict

Sugi Predict / Compounds / SCHEMBL2483464

SCHEMBL2483464

SCHEMBL2483464

O=C(ON1CCCCC1)C(=O)ON1CCCCC1

nearest known ligand 0.39

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.39
▸ POLB P06746 2/20 0.33
▸ HPGD P15428 2/20 0.33
▸ MMP1 P03956 1/20 0.33
▸ MMP2 P08253 1/20 0.33
▸ MMP3 P08254 1/20 0.33
▸ MMP9 P14780 1/20 0.33
▸ GAA P10253 1/20 0.32
▸ CA2 P00918 1/20 0.32
▸ CHKA P35790 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.31
▸ CYP1A2 P05177 1/20 0.30
▸ MAPK1 P28482 1/20 0.30
▸ SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL11439691 0.97 ALDH1A1 (0.38) ALDH1A1POLBHPGDMMP1MMP2
SCHEMBL3717460 0.97 ALDH1A1 (0.35) ALDH1A1POLB
SCHEMBL5855885 0.89 ALDH1A1 (0.36) ALDH1A1POLBHPGDMMP1MMP2
SCHEMBL3849401 0.88 FKBP1A (0.34) ALDH1A1MAPTSMN1; SMN2
SCHEMBL5857825 0.86 ALDH1A1 (0.32) ALDH1A1
SCHEMBL5919599 0.85 ALDH1A1 (0.34) ALDH1A1CYP1A2
SCHEMBL1114107 0.82 ALDH1A1 (0.39) ALDH1A1POLBHPGDMMP1MMP2
SCHEMBL2309904 0.81 ALDH1A1 (0.31) ALDH1A1GAAMAPT
SCHEMBL1411118 0.81 ALDH1A1 (0.41) ALDH1A1
SCHEMBL10594339 0.80 ALDH1A1 (0.38) ALDH1A1POLBHPGDMMP1MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108064425-A For the electrolyte preparations of lithium ion battery 野猫技术开发公司 2018-05-22 — — CN claimed
CN-101595098-B 1,2,4-triazole derivatives as sigma receptor inhibitors ESTEVE LABOR DR 2012-07-18 — — CN claimed
CN-101595098-A As 1,2 of sigma receptor inhibitors, the 4-triazole derivative ESTEVE LABOR DR (ES) 2009-12-02 — — CN claimed
CN-120136842-A Indole piperidine compound and preparation method and application thereof 江苏海洋大学 2025-06-13 — — CN disclosed
US-20200179254-A1 IMPROVED CONDITIONING HAIR TREATMENT PRODUCT WITH WASHOUT PROTECTION HENKEL AG & CO. KGAA (DE) 2020-06-11 — — US disclosed
US-20190240129-A1 CONDITIONING HAIR TREATMENT PRODUCT WITH WASHOUT PROTECTION HENKEL AG & CO. KGAA (DE) 2019-08-08 — — US disclosed
EP-3518878-A1 IMPROVED CONDITIONING HAIR TREATMENT PRODUCT WITH WASHOUT PROTECTION Henkel AG & Co. KGaA (DE) 2019-08-07 — — EP disclosed
US-20190216714-A1 IMPROVED CONDITIONING HAIR TREATMENT PRODUCT WITH WASHOUT PROTECTION HENKEL AG & CO. KGAA (DE) 2019-07-18 — — US disclosed
US-20190216703-A1 IMPROVED CONDITIONING HAIR TREATMENT PRODUCT WITH WASHOUT PROTECTION HENKEL AG & CO. KGAA (DE) 2019-07-18 — — US disclosed
CN-104887675-B Application of [(aryloxy group) (the heteroaryl)] methylpiperidine derivatives in the drug for preparing treatment depression 江苏恩华药业股份有限公司 2018-08-07 — — CN disclosed
CN-108140892-A Electrolyte formulation for lithium ion batteries 野猫技术开发公司 2018-06-08 — — CN disclosed
CN-1374959-A Piperidine quinolyl propyl derivatives, preparation method and compositions containing same AVENTIS PHARMA SA (FR) 2002-10-16 — — CN disclosed
WO-2000006082-A2 TREATMENT OF ANXIETY DISORDERS ELI LILLY AND COMPANY (US) 2000-02-10 — — WO disclosed
CN-1104412-A Peripheral Vasodilating agent containing N-acylated 4-amino piperidine derivatives as active ingredients OTSUKA PHARMA CO LTD (JP) 1995-06-28 — — CN disclosed
CN-1092420-A Compound GLAXO GROUP LTD (GB) 1994-09-21 — — CN disclosed
CN-1020723-C Process for 4-phenyl-4-[N-(phenyl) amido] piperidine derivatives BOC INC (US) 1993-05-19 — — CN disclosed
CN-1061963-A Be used as the croak pyridine class of the 4-replacement of medicine SMITH KLINE FRENCH LAB (GB) 1992-06-17 — — CN disclosed
CN-1041585-A The application process of 4-phenyl-4-[N-(phenyl) amido 1 piperidine derivative and pharmaceutical compositions and this compound BOC INC (US) 1990-04-25 — — CN disclosed
CN-1037332-A Piperidines and their preparation and purposes FERROSAN AS (DK) 1989-11-22 — — CN disclosed
US-3978079-A DIPHTHALIMIDO, DISUCCINIMIDO AND DIMALEIMIDO OXALATES AMERICAN CYANAMID COMPANY (US) 1976-08-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190240129-A1 CONDITIONING HAIR TREATMENT PRODUCT WITH WASHOUT PROTECTION KRT18, CUTA, S100A10 ALDH1A1 1010/4885POLB 1221/4885HPGD 2076/4885
US-20190216703-A1 IMPROVED CONDITIONING HAIR TREATMENT PRODUCT WITH WASHOUT PROTECTION KRT18, SRRM2, IK ALDH1A1 3629/4885POLB 702/4885HPGD 634/4885
US-20190216714-A1 IMPROVED CONDITIONING HAIR TREATMENT PRODUCT WITH WASHOUT PROTECTION KRT18, CD44, PCNA ALDH1A1 1465/4885POLB 932/4885HPGD 3201/4885
US-20200179254-A1 IMPROVED CONDITIONING HAIR TREATMENT PRODUCT WITH WASHOUT PROTECTION KRT18, CUTA, DSG1 ALDH1A1 1179/4885POLB 598/4885HPGD 3478/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.